| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | TUDOR | 3.47e-05 | 23 | 52 | 3 | PS50304 | |
| Domain | Tudor | 7.84e-05 | 30 | 52 | 3 | IPR002999 | |
| Domain | Myosin_TH1 | 1.58e-04 | 7 | 52 | 2 | PF06017 | |
| Domain | Myosin_TH1 | 1.58e-04 | 7 | 52 | 2 | IPR010926 | |
| Domain | TH1 | 1.58e-04 | 7 | 52 | 2 | PS51757 | |
| Domain | Rap_GAP | 3.37e-04 | 10 | 52 | 2 | PF02145 | |
| Domain | Rap_GAP_dom | 4.11e-04 | 11 | 52 | 2 | IPR000331 | |
| Domain | RAPGAP | 4.11e-04 | 11 | 52 | 2 | PS50085 | |
| Domain | PDZ | 6.36e-04 | 141 | 52 | 4 | PF00595 | |
| Domain | TUDOR | 6.77e-04 | 14 | 52 | 2 | PF00567 | |
| Domain | PDZ | 7.63e-04 | 148 | 52 | 4 | SM00228 | |
| Domain | - | 8.02e-04 | 150 | 52 | 4 | 2.30.42.10 | |
| Domain | PDZ | 8.22e-04 | 151 | 52 | 4 | PS50106 | |
| Domain | PDZ | 8.43e-04 | 152 | 52 | 4 | IPR001478 | |
| Domain | Peptidase_aspartic_dom | 1.01e-03 | 17 | 52 | 2 | IPR021109 | |
| Domain | A/G_cyclase_CS | 1.01e-03 | 17 | 52 | 2 | IPR018297 | |
| Domain | Nucleotide_cyclase | 1.13e-03 | 18 | 52 | 2 | IPR029787 | |
| Domain | - | 1.13e-03 | 18 | 52 | 2 | 3.30.70.1230 | |
| Domain | GUANYLATE_CYCLASE_1 | 1.26e-03 | 19 | 52 | 2 | PS00452 | |
| Domain | Guanylate_cyc | 1.26e-03 | 19 | 52 | 2 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 1.26e-03 | 19 | 52 | 2 | PS50125 | |
| Domain | A/G_cyclase | 1.26e-03 | 19 | 52 | 2 | IPR001054 | |
| Domain | CYCc | 1.26e-03 | 19 | 52 | 2 | SM00044 | |
| Domain | TUDOR | 2.55e-03 | 27 | 52 | 2 | SM00333 | |
| Domain | Myosin_head_motor_dom | 5.01e-03 | 38 | 52 | 2 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 5.01e-03 | 38 | 52 | 2 | PS51456 | |
| Domain | Myosin_head | 5.01e-03 | 38 | 52 | 2 | PF00063 | |
| Domain | MYSc | 5.01e-03 | 38 | 52 | 2 | SM00242 | |
| Domain | Peptidase_M12B_N | 5.27e-03 | 39 | 52 | 2 | IPR002870 | |
| Domain | Pep_M12B_propep | 5.27e-03 | 39 | 52 | 2 | PF01562 | |
| Domain | DISINTEGRIN_1 | 5.54e-03 | 40 | 52 | 2 | PS00427 | |
| Domain | Reprolysin | 5.54e-03 | 40 | 52 | 2 | PF01421 | |
| Domain | ADAM_MEPRO | 5.54e-03 | 40 | 52 | 2 | PS50215 | |
| Domain | DISINTEGRIN_2 | 5.54e-03 | 40 | 52 | 2 | PS50214 | |
| Domain | Peptidase_M12B | 5.54e-03 | 40 | 52 | 2 | IPR001590 | |
| Domain | Disintegrin_dom | 5.82e-03 | 41 | 52 | 2 | IPR001762 | |
| Pubmed | 5.56e-07 | 104 | 53 | 5 | 9205841 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 1.28e-06 | 123 | 53 | 5 | 26912792 | |
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 20221248 | ||
| Pubmed | 3.07e-05 | 396 | 53 | 6 | 26687479 | ||
| Pubmed | Myosin-I isozymes in neonatal rodent auditory and vestibular epithelia. | 3.40e-05 | 6 | 53 | 2 | 12486594 | |
| Pubmed | 3.40e-05 | 6 | 53 | 2 | 33245046 | ||
| Pubmed | 5.08e-05 | 263 | 53 | 5 | 34702444 | ||
| Pubmed | MDN1 PHF20L1 MYO1D MB MPHOSPH8 ZFC3H1 SIPA1L2 ARHGAP21 CAVIN2 RYR2 | 5.57e-05 | 1442 | 53 | 10 | 35575683 | |
| Pubmed | 5.93e-05 | 446 | 53 | 6 | 24255178 | ||
| Pubmed | A role for Saccharomyces cerevisiae Centrin (Cdc31) in mitochondrial function and biogenesis. | 1.49e-04 | 12 | 53 | 2 | 30251372 | |
| Pubmed | Mutations in the RNA granule component TDRD7 cause cataract and glaucoma. | 2.70e-04 | 16 | 53 | 2 | 21436445 | |
| Pubmed | 2.95e-04 | 209 | 53 | 4 | 36779422 | ||
| Pubmed | 3.05e-04 | 17 | 53 | 2 | 20479123 | ||
| Pubmed | 3.43e-04 | 18 | 53 | 2 | 20602751 | ||
| Pubmed | 3.87e-04 | 407 | 53 | 5 | 12693553 | ||
| Pubmed | 3.98e-04 | 634 | 53 | 6 | 34591612 | ||
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 4.37e-04 | 232 | 53 | 4 | 25515538 | |
| Pubmed | 4.75e-04 | 1215 | 53 | 8 | 15146197 | ||
| Pubmed | 5.01e-04 | 101 | 53 | 3 | 9872452 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 5.18e-04 | 934 | 53 | 7 | 33916271 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 5.52e-04 | 440 | 53 | 5 | 34244565 | |
| Pubmed | A genomic analysis of rat proteases and protease inhibitors. | 5.65e-04 | 23 | 53 | 2 | 15060002 | |
| Pubmed | 5.77e-04 | 106 | 53 | 3 | 19394292 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 6.55e-04 | 457 | 53 | 5 | 32344865 | |
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 6.90e-04 | 262 | 53 | 4 | 36880596 | |
| Pubmed | Blood pressure is regulated by an alpha1D-adrenergic receptor/dystrophin signalosome. | 7.80e-04 | 27 | 53 | 2 | 18468998 | |
| Pubmed | 9.01e-04 | 29 | 53 | 2 | 27120339 | ||
| Pubmed | 9.01e-04 | 29 | 53 | 2 | 23396134 | ||
| Pubmed | iRhom2 mutation leads to aberrant hair follicle differentiation in mice. | 9.64e-04 | 30 | 53 | 2 | 25546423 | |
| Pubmed | A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. | 1.11e-03 | 298 | 53 | 4 | 32353859 | |
| Pubmed | 1.31e-03 | 35 | 53 | 2 | 32504627 | ||
| Pubmed | 1.31e-03 | 35 | 53 | 2 | 33864728 | ||
| Pubmed | 1.46e-03 | 1116 | 53 | 7 | 31753913 | ||
| Interaction | FBLN5 interactions | 3.31e-06 | 159 | 52 | 6 | int:FBLN5 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p13 | 1.74e-03 | 53 | 53 | 2 | chr7p13 | |
| GeneFamily | Tudor domain containing | 7.40e-05 | 37 | 40 | 3 | 780 | |
| GeneFamily | Myosins, class I | 1.33e-04 | 8 | 40 | 2 | 1097 | |
| GeneFamily | PDZ domain containing | 3.47e-04 | 152 | 40 | 4 | 1220 | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.19e-06 | 177 | 53 | 5 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.43e-06 | 194 | 53 | 5 | 5c3b2b05d1e4f146551fe4c920263d8e6ca34de3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.43e-06 | 194 | 53 | 5 | ab9cad697f9209d2889bc02b43b502dfeb2ebfef | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.89e-06 | 199 | 53 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.89e-06 | 199 | 53 | 5 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | facs-Thymus-nan-3m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-05 | 140 | 53 | 4 | 115bd770a9d5e6f007a9aa0eadf5dba46d500107 | |
| ToppCell | facs-Thymus-nan-3m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-05 | 140 | 53 | 4 | 22d126e80bf7d9c0ca6ec686b5cc66fa584a1ab6 | |
| ToppCell | facs-Thymus-nan-3m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-05 | 140 | 53 | 4 | 62d1ef8cb78618ed89cac7ec89d7f54de06a90c7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.39e-05 | 154 | 53 | 4 | b6e982e341c6cfb6ff80a318078fcb10c36d182f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.39e-05 | 154 | 53 | 4 | d76fd51a4587decbfe1dde1c8a9b880c5fa18e4a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-05 | 159 | 53 | 4 | 5ca96db4281abb5f646150ccf36adc66ab201c78 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.99e-05 | 170 | 53 | 4 | 8e774af244cfe787fa0ea2b6be0c3c2d00bfe4fc | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.99e-05 | 170 | 53 | 4 | f5140eb9313c0d1bb31f8a761d9c062c56733a61 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.83e-05 | 177 | 53 | 4 | 4943d040eee0f9dceaddc7498171281d170e271f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.83e-05 | 177 | 53 | 4 | 3f2272b577c862dba8ccfb41184054bbd0ace6f5 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 184 | 53 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 184 | 53 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 184 | 53 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LA-07._Pericyte|LA / Chamber and Cluster_Paper | 6.92e-05 | 185 | 53 | 4 | ba5baa4d7f097108622674de5b7f4fd279843d24 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_bright-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.07e-05 | 186 | 53 | 4 | 5ad37549592eab23f166196ebf0cb9c8ddf26082 | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.22e-05 | 187 | 53 | 4 | ea9d34bcd3bd1f36745846309ede349773de501a | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_bright|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.52e-05 | 189 | 53 | 4 | 3e148accffc6ab249fb0dff7f3bf5a7fff9da773 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.83e-05 | 191 | 53 | 4 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.99e-05 | 192 | 53 | 4 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 8.15e-05 | 193 | 53 | 4 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.32e-05 | 194 | 53 | 4 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | Mild/Remission-B_naive-8|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.49e-05 | 195 | 53 | 4 | 0a3221e4d1fa31a35868bdda0f0cc873c233b407 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.65e-05 | 196 | 53 | 4 | b8759e6231e0254797d6c30930407b79440c57bb | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.18e-05 | 199 | 53 | 4 | 214a6a267e77e5508867b9eb48c4fbc7855ed0a0 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.18e-05 | 199 | 53 | 4 | 1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.36e-05 | 200 | 53 | 4 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Mesenchymal|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 9.36e-05 | 200 | 53 | 4 | 5c638c80661017c85f9390f1b398ac7728c8f001 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Mesenchymal-BMP_responsible_cell|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 9.36e-05 | 200 | 53 | 4 | 604a88633d4162337e394155c7346dbdef8b9f5a | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.36e-05 | 200 | 53 | 4 | acdef0b9096c774040948fc75621ff2b08ea2ee8 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.36e-05 | 200 | 53 | 4 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.36e-05 | 200 | 53 | 4 | 091a18d6efed81cab99955c3047f172170f70476 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.36e-05 | 200 | 53 | 4 | 3b8513defe25262ab4b492345b2628570eaefd17 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.36e-05 | 200 | 53 | 4 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| Drug | dmid | 4.26e-06 | 14 | 53 | 3 | CID000151469 | |
| Drug | Oxolinic acid [14698-29-4]; Down 200; 15.4uM; PC3; HT_HG-U133A | 6.55e-06 | 198 | 53 | 6 | 5094_DN | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 6.46e-05 | 801 | 51 | 8 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | PR interval | 2.05e-04 | 495 | 51 | 6 | EFO_0004462 | |
| Disease | testosterone measurement | 3.02e-04 | 1275 | 51 | 9 | EFO_0004908 | |
| Disease | birth weight | 6.21e-04 | 399 | 51 | 5 | EFO_0004344 | |
| Disease | lifestyle measurement, alcohol consumption measurement | 1.05e-03 | 115 | 51 | 3 | EFO_0007878, EFO_0010724 | |
| Disease | Hirschsprung Disease | 1.32e-03 | 31 | 51 | 2 | C0019569 | |
| Disease | aggressive behaviour measurement, childhood aggressive behaviour measurement | 1.41e-03 | 32 | 51 | 2 | EFO_0007663, EFO_0007826 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 1.52e-03 | 131 | 51 | 3 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 1.52e-03 | 131 | 51 | 3 | C4552091 | |
| Disease | Juvenile arthritis | 1.52e-03 | 131 | 51 | 3 | C3495559 | |
| Disease | Juvenile psoriatic arthritis | 1.52e-03 | 131 | 51 | 3 | C3714758 | |
| Disease | Juvenile-Onset Still Disease | 1.66e-03 | 135 | 51 | 3 | C0087031 | |
| Disease | facial emotion recognition measurement | 1.68e-03 | 35 | 51 | 2 | EFO_0008329 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NLEDLKFPENMGHGS | 696 | Q9HAR2 | |
| AAEHSAQVGDPEMKN | 3411 | Q8TCU4 | |
| QAAGIHDAIMAFPEG | 701 | Q9NP58 | |
| DMEQPQHGGAKDSAA | 236 | Q8NFD5 | |
| AMGDLDSGDFQPAAH | 396 | P20594 | |
| EDGHGQQRDPYLKEM | 431 | P51828 | |
| PIMKADGNEYEDGHN | 166 | P59510 | |
| GSANDSQHDPGKMFI | 11 | Q96DH6 | |
| NGHPLKAFVDSGAQM | 251 | Q8WTU0 | |
| GEHDSKMQPDEFFGI | 946 | Q86T65 | |
| HDGPLVQAMKEDGFF | 1451 | Q9NU22 | |
| EMAHGSQEAEAPGAV | 141 | Q8IVD9 | |
| ADGPKAGFQELDHMG | 1781 | Q6PRD1 | |
| VGQLKADEDPIMGFH | 86 | P61970 | |
| PGKIFKEMFGDQNDD | 381 | P78552 | |
| GGYENVPTDDIHMKQ | 601 | O00469 | |
| MGKQNIPLDGHEADE | 176 | O43422 | |
| EPEVKYVGNMHGNEA | 76 | P15169 | |
| NHNGLKEADFLGGME | 101 | Q96A23 | |
| MAEQHGAPEQAAAGK | 1 | P26998 | |
| AAEMAVPGSEFEGHK | 1016 | Q7Z591 | |
| AKAFGHRSIDPMDGN | 106 | P22680 | |
| PHGGEAQKANLTDME | 1956 | Q8NDH2 | |
| MGEDAAQAEKFQHPG | 1 | O95810 | |
| FHAPKIGSNGVEMAA | 246 | Q6IQ49 | |
| AKDGNVVEPDMSAGF | 2446 | Q92736 | |
| GQDMGLEHGFEKPLD | 301 | Q99549 | |
| KGIHAGQMGENDSFP | 431 | Q3MIW9 | |
| HGMPEKNPAEGNTVF | 911 | A8MW92 | |
| FHELGEPQAAMFKVG | 851 | Q6ZN16 | |
| FFGDKTMPGGNDHEI | 206 | O15305 | |
| HFNFDVMELPEQDGG | 976 | A6NKG5 | |
| DMEKEISNALGHGPQ | 371 | Q9HC62 | |
| MAKYGEHEASPDNGQ | 1 | P46939 | |
| GDEMNAHFPQSELGR | 591 | O95602 | |
| KDVQGMEDSHGVNFP | 251 | Q587J7 | |
| NSDDKHFGSGDLMDP | 1236 | Q9P2F8 | |
| KEHQNFFGMDESLGP | 226 | Q96FS4 | |
| DAGQAHGDNDIKAMV | 416 | Q8NHU6 | |
| HMDEDGFEKDPFPNS | 771 | P78536 | |
| MEKFVDPGNHNSGID | 116 | Q9NY35 | |
| LGLPDENKGDMHYDA | 111 | Q96S66 | |
| GVMGQQEKHSLPADF | 11 | Q9Y4G8 | |
| TPGIGGMQQHFFDDE | 2116 | P12270 | |
| FKHEDPMGQQGSLGE | 176 | P19544 | |
| PGDFGADAQGAMNKA | 121 | P02144 | |
| EHSKDPGFGQMDELQ | 281 | O15060 | |
| PADDMFGVGNHKVNA | 1776 | Q5T5U3 | |
| CKGNFDDDMFNHQVP | 1731 | O60293 | |
| KRQEAADGHPEMGFH | 66 | O14628 | |
| DSAAAHMGAFKLNPG | 51 | O95409 | |
| MDINFDFKGDPIGGH | 166 | O94832 | |
| MDINFDFKGDPIGGH | 166 | B0I1T2 |